Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes.
about
Sulphonylurea monotherapy for patients with type 2 diabetes mellitusSulphonylurea monotherapy for patients with type 2 diabetes mellitusAlpha-glucosidase inhibitors for type 2 diabetes mellitusSafety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trialsAcarbose treatment and the risk of cardiovascular disease in type 2 diabetic patients: a nationwide seven-year follow-up study.Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian.Comparison of glucose lowering effect of metformin and acarbose in type 2 diabetes mellitus: a meta-analysisThe effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.Lipid effects and cardiovascular disease risk associated with glucose-lowering medications.Is gliclazide a sulfonylurea with difference? A review in 2016.Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations.Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials.
P2860
Q24186660-C4F47B0D-258D-4D0C-B2EA-CE71223ED74EQ24197884-D6A1A25A-B4F2-4736-89BB-6447C2872388Q24246908-4E4EA53E-B189-413B-ADD0-734879DF56FFQ27022613-4B737BED-8656-4766-8E5B-B14AF6A026E4Q34100788-5D6B873C-D97B-4B94-93BB-7DA11D6635E1Q35043812-2D9AC0B6-9844-41CF-BA37-B13BA1502AD6Q35592932-D832D404-06FD-4211-AAD6-3363B09DC8E6Q35640348-2836D60C-2965-45D1-AA8B-67EDC1C9E4DFQ37875220-D4AEA158-108C-4656-87B8-2C320FD63A0DQ38511039-32996FCA-7B2E-4FCC-B041-8D68F942401BQ38754132-485AD170-0F29-4E10-BB34-F979E73D8E21Q39420555-4EDCAFB1-D7B9-4976-9CA2-A8AF1956C76CQ43409321-23B658FB-E400-4371-9D00-15361C7B8146
P2860
Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Comparison of acarbose and gli ...... patients with type 2 diabetes.
@ast
Comparison of acarbose and gli ...... patients with type 2 diabetes.
@en
type
label
Comparison of acarbose and gli ...... patients with type 2 diabetes.
@ast
Comparison of acarbose and gli ...... patients with type 2 diabetes.
@en
prefLabel
Comparison of acarbose and gli ...... patients with type 2 diabetes.
@ast
Comparison of acarbose and gli ...... patients with type 2 diabetes.
@en
P2093
P1476
Comparison of acarbose and gli ...... patients with type 2 diabetes.
@en
P2093
Demirel HO
Karşidağ K
P304
P356
10.1185/030079901750120231
P407
P577
2001-01-01T00:00:00Z